ARTICLE | Company News
Dyax, Becton in antibody deal
June 13, 2001 7:00 AM UTC
The companies will discovery antibodies using DYAX's phage display technology. BDX has exclusive rights to market resulting antibodies to the life sciences market as research products, while DYAX reta...